Search

Author/Creator Schutzman, Jennifer L.

1. A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors. (4th December 2017)

Authors:
Leong, Stephen; Moss, Rebecca A.; Bowles, Daniel W.; Ware, Joseph A.; Zhou, Jing; Spoerke, Jill M.; Lackner, Mark R.; Shankar, Geetha; Schutzman, Jennifer L.; van der Noll, Ruud; Voest, Emile E.; Schellens, Jan H.M.
Journal:
Oncologist
Issue:
Volume 22:Number 12(2017)
Page Start:
1491
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer. (November 2017)

Authors:
Soria, Jean-Charles; Adjei, Alex A.; Bahleda, Rastilav; Besse, Benjamin; Ferte, Charles; Planchard, David; Zhou, Jing; Ware, Joseph; Morrissey, Kari; Shankar, Geetha; Lin, Wei; Schutzman, Jennifer L.; Dy, Grace K.; Groen, Harry J.M.
Journal:
European journal of cancer
Issue:
Volume 86(2017)
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search